Skip to content

    Atea Pharmaceuticals (AVIR) stock price & financials

    View AVIR earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+48.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$37.20M
    -$39.03M
    -$39.04M
    -$41.34M
    -$45.57M
    -22.5%
    -$54.93M
    -40.8%
    -$48.01M
    -23.0%
    -$35.10M
    +15.1%
    Weakening
    Net Profit
    -$31.15M
    -$33.54M
    -$34.27M
    -$37.16M
    -$42.05M
    -35.0%
    -$44.87M
    -33.8%
    -$45.44M
    -32.6%
    -$32.93M
    +11.4%
    Weakening
    EPS
    $-0.37
    $-0.40
    $-0.44
    $-0.53
    -43.2%
    $-0.57
    -42.5%
    $-0.41
    +6.8%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$30.93M
    -$33.32M
    -$34.07M
    -$36.95M
    -$41.85M
    -35.3%
    -$51.63M
    -55.0%
    -$45.39M
    -33.2%
    -$32.91M
    +10.9%
    Weakening
    MarginsOPM
    Tax
    -0.7%
    -0.7%
    -0.6%
    -0.6%
    -0.5%
    +35.6%
    13.1%
    -0.1%
    +81.7%
    -0.1%
    +87.5%
    Strengthening
    ReturnsROIC
    5.2%
    5.6%
    5.7%
    6.2%
    7.0%
    +35.0%
    7.5%
    +33.8%
    7.6%
    +32.6%
    5.5%
    -11.4%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$34.49M$21.66M$850.12M$764.38M$188.46M$143.82M$64.70M$95.71M$76.55M
    Short-Term Investments
    Total Current Assets$21.91M$863.48M$772.40M$660.92M$590.46M$462.36M$310.99M$228.66M
    Net PP&E$41.0K$48.0K$184.0K$4.09M$3.12M$2.12M$1.09M$569.0K
    Goodwill
    Intangibles
    Total Assets$22.07M$863.63M$772.89M$666.71M$594.97M$464.67M$315.22M$232.28M
    LiabilitiesTotal Current Liabilities$2.44M$315.80M$56.88M$18.48M$32.38M$18.60M$39.78M$28.12M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$2.40M$1.64M$842.0K$0
    Total Liabilities$2.53M$315.83M$62.81M$26.14M$39.78M$25.80M$39.78M$28.12M
    EquityCommon Stock & APIC$10.0K$82.0K$83.0K$83.0K$83.0K$84.0K$78.0K$80.0K
    Retained Earnings-$54.21M-$65.16M$56.03M-$59.88M-$195.84M-$364.22M-$522.57M-$600.94M
    Total Equity-$36.16M-$49.57M$547.80M$710.08M$640.57M$555.19M$438.87M$275.43M$204.16M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$7.91M-$12.83M$296.73M-$87.00M-$120.98M-$85.39M-$135.50M-$132.03M-$152.07M
    Cash from Investing-$12.0K-$2.0K-$26.0K-$4.0K-$455.41M$40.30M$56.10M$188.79M$151.95M
    Cash from Financing$27.48M$531.75M$1.47M$370.0K$257.0K$267.0K-$25.75M-$11.05M
    SummaryCapital Expenditure-$12.0K-$2.0K-$26.0K-$4.0K-$1.94M
    Free Cash Flow-$7.92M-$12.83M$296.71M-$87.01M-$122.92M
    FCF Margin610.1%-24.8%

    Ratios